Now showing items 1-4 of 4
Recommended Guidelines for the Conduct and Evaluation of Prognostic Studies in Veterinary Oncology
(Sage Publications Inc, 2011-01-01)
There is an increasing need for more accurate prognostic and predictive markers in veterinary oncology because of an increasing number of treatment options, the increased financial costs associated with treatment, and the ...
Combined Gemcitabine and Carboplatin Therapy for Carcinomas in Dogs
(Wiley-Blackwell Publishing, Inc, 2009-01-01)
Background: Response and adverse reactions to combined gemcitabine (GEM) and carboplatin (CARBO) therapy in dogs with carcinomas are not documented. Hypothesis: GEM and CARBO are safe for the treatment of dogs with ...
Safety of concurrent administration of dexrazoxane and doxorubicin in the canine cancer patient
(Wiley-Blackwell Publishing, Inc, 2010-12-01)
Doxorubicinmay cause a rare but serious cardiotoxicity. Dexrazoxane is a cardioprotectant drug used to reduce the risk of cardiotoxicity in human patients. In this study, 25 tumour-bearing dogs were treated with concurrent ...
Treatment with DAV for Advanced-Stage Hemangiosarcoma in Dogs
(Amer Animal Hospital Assoc, 2011-05-01)
Hemangiosarcoma (HSA) is an aggressive disease that is fairly common in the dog. The authors evaluated a doxorubicin, dacarbazine, and vincristine (DAV) combination protocol in dogs with nonresectable stage II and stage ...